FAT1 and gastric adenocarcinoma: In conclusion, our study revealed that FAT mutations enhanced tumor immunogenicity (e.g., TMB and DDR mutations) and contributed to an inflammatory TME, thereby significantly improving the prognosis of patients with STAD, which might be a positive prognostic marker for STAD.